CPC in Adult Refractory Glaucoma
Launched by SOHAG UNIVERSITY · Jun 4, 2021
Trial Information
Current as of July 04, 2025
Unknown status
Keywords
ClinConnect Summary
A hospital -based, prospective interventional non comparative case series study.This study will be conducted on patients with refractory glaucoma whose ages are 18 years and older.They will be subjected to Transscleral Diode Laser Cyclophotocoagulation.
Postoperative evaluation will be scheduled for the first day postoperative, then 1 week later and then at 1st, 3rd, month postoperative.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * Inclusion Criteria:
- • 1. Patients with refractory glaucoma aging 18 years and older.
- • 2. Both sexes are included.
- • 3. Patients Capable of giving informed consent.
- • 4. Pseudophkic glaucoma.
- • 5. Aphakic glaucoma.
- • 6. Silicon oil induced glaucoma.
- • 7. Neovascular glaucoma.
- • 8. Inflammatory glaucoma.
- Exclusion Criteria:
- • 1. Patients \<18 years of age.
- • 2. Patients controlled on regular antiglaucomatous therapy.
- • 3. Patients who cannot do regular follow up visits.
- • 4. Diffuse scleral staphyloma at the site of CPC.
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sohag, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials